glp 1 during perimenopause A thoughtful approach to GLP-1 therapy, especially perimenopause. These results are just 3.5 months apart! At baseline, this patient was already at a healthy weight. The goal was not drastic weight One Year on a GLP-1

The broader picture is that the next generation of obesity treatments involves multi-target approaches, whether through single molecules activating multiple receptors (tirzepatide, retatrutide, survodutide, mazdutide) or through combination therapies pairing separate compounds (CagriSema)

Chicory root inulin works differently: It reaches your colon, feeds good bacteria, and supports healthy movement

This approach recognizes that simply identifying the presence of autoimmunity provides insufficient information for developing personalized treatment plans aimed at addressing root causes

Premature shifts into telogen, triggered by stress or hormonal changes, lead to noticeable thinning and increased shedding